The latest ophthalmology news – in brief
Phoebe Harkin | | Quick Read
- Researchers at Augusta University have discovered a potential treatment path for patients with optic nerve trauma. The team used a mouse model to show that removing the inflammatory enzyme arginase 2, which increases with injury, decreases neuron death in the retina, as well as the degeneration of nerve fibers that connect neurons in the brain. In fact, brain-derived neurotropic factor increased upon removing A2, suggesting that the axons were attempting to repair themselves and, ultimately, to reconnect with the brain. The team are now pursuing several new lines of investigation into the role of A2 in optic nerve injuries, for which there is currently no targeted therapy (1).
Read the full article now
Log in or register to read this article in full and gain access to The Ophthalmologist’s entire content archive. It’s FREE and always will be!
Login if you already created an account
Or register now - it’s free and always will be!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Ophthalmologist magazine